CSIMarket
 
Steris Plc  (NYSE: STE)
Other Ticker:  
 
 
Price: $235.6700 $-0.56 -0.237%
Day's High: $237.74 Week Perf: -2.35 %
Day's Low: $ 234.53 30 Day Perf: -6.68 %
Volume (M): 666 52 Wk High: $ 252.79
Volume (M$): $ 156,909 52 Wk Avg: $226.06
Open: $236.96 52 Wk Low: $200.98



 Market Capitalization (Millions $) 23,363
 Shares Outstanding (Millions) 99
 Employees 18,000
 Revenues (TTM) (Millions $) 5,460
 Net Income (TTM) (Millions $) 616
 Cash Flow (TTM) (Millions $) -35
 Capital Exp. (TTM) (Millions $) 370

Steris Plc
Steris Plc is a prominent global leader in the provision of sterilization and infection prevention solutions across various industries, including healthcare, life sciences, industrial manufacturing, and pharmaceuticals. Founded in 1985 and headquartered in Dublin, Ireland, the company has established itself as a crucial player in ensuring safety and efficacy in environments that require stringent infection control measures.

Product Offerings
Steris Plc offers an extensive range of products designed to meet the diverse needs of its customers:
- Sterilizers: These are essential for the sterilization of surgical instruments, medical devices, and laboratory equipment, ensuring that they are free from all microorganisms.
- Washer-Disinfectors: Designed to clean and disinfect medical equipment and instruments, these devices are critical in healthcare settings to maintain hygiene standards.
- Endoscope Cleaning and Disinfection Systems: These systems play a vital role in ensuring that endoscopes are effectively cleaned and sterilized between uses to avert cross-contamination.
- Biological Indicators: Used to monitor the effectiveness of sterilization processes, these indicators help in validating that the sterilization parameters have been met.

Services
Beyond product offerings, Steris Plc provides a range of services that support its customers:
- Equipment Maintenance: This includes routine maintenance and repairs to ensure that sterilization equipment operates efficiently and effectively.
- Technical Support: Steris Plc offers expert technical assistance to address any operational challenges that customers may face with their sterilization systems.
- Training Services: To ensure optimal performance and compliance, the company provides training for healthcare and laboratory personnel on the proper use of its products and systems.

Market Segments
The largest market for Steris Plc is the healthcare sector, where the company supplies products and services to healthcare providers. These solutions are designed to protect patients from healthcare-associated infections (HAIs). Steris Plcs offerings help maintain sterile environments in operating rooms, patient care areas, and other clinical settings.

In addition to healthcare, Steris Plcs life sciences segment caters to biopharmaceutical manufacturing companies, providing sterilization and infection prevention solutions critical for preventing contamination and ensuring the quality of biopharmaceutical products.

The company's industrial segment addresses the needs of manufacturing processes that require sterilization and contamination control, particularly in settings such as research laboratories and biotechnology industries.

Commitment to Sustainability and Corporate Responsibility
Steris Plc is dedicated to sustainability and corporate responsibility. The company actively seeks to minimize its environmental footprint through various initiatives in its operations, products, and supply chain practices. This commitment extends to promoting diversity and inclusion within its workforce, aiming to create a supportive and dynamic working environment.

Overall Impact
Through its comprehensive range of infection prevention and sterilization solutions, Steris Plc plays a vital role in improving patient safety, ensuring product integrity, and creating cleaner environments across multiple industries. The company's focus on innovation and customer satisfaction has solidified its position as a trusted leader in the sterilization and infection prevention market.


   Company Address: 70 Sir John Rogerson s Quay, Dublin 2, 0
   Company Phone Number: 232 2000   Stock Exchange / Ticker: NYSE STE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
IART   -4.61%    
MLSS   -0.12%    
SYK   -0.46%    
ATR   -0.57%    
DHR   -2.13%    
ECL   -1.13%    
• View Complete Report
   



Dividend

STERIS Declares Dividend of $0.57 per share

Published Tue, Jan 28 2025 10:00 PM UTC

STERIS Strengthens Shareholder Confidence with New Dividend Declaration Amid Growth AspirationsIn a notable commitment to enhancing shareholder value, STERIS plc (NYSE: STE) declared an interim quarterly dividend of $0.57 per share on January 28, 2025. The dividend will be paid out on March 21, 2025, to all shareholders on record as of the close of business on February 20, ...

Dividend

STERIS Strengthens Shareholder Confidence with Steady Dividend Amid Growth Ambitions,

Published Wed, Oct 30 2024 8:30 PM UTC

STERIS plc Announces Quarterly Dividend, Reaffirming Shareholder Commitment Amid Strategic Growth Overview of Dividend AnnouncementDUBLIN, IRELAND, Oct. 30, 2024 STERIS plc (NYSE: STE), a global leader in infection prevention, announced today a quarterly interim dividend of $0.57 per share. This commitment continues the Company s tradition of returning capital to sharehold...

Dividend

STERIS Boosts Shareholder Confidence with New Dividend Hike

Published Wed, Jul 31 2024 8:30 PM UTC

STERIS Increases Dividend Amidst Growing Earnings: Promises Steady Returns for Shareholders
In a recent announcement that signifies stability and growth, STERIS plc (NYSE: STE) declared a quarterly interim dividend of $0.57 per share, marking a $0.05 increase from the previous payout. This decision, unveiled in a press release dated July 31, 2024, highlights the company ...

Merger and Acquisition

STERIS to Divest Dental Segment to Peak Rock Capital, Boosting Focus on Core Healthcare Solutions

Published Thu, Apr 11 2024 10:58 AM UTC



DUBLIN, IRELAND, April 11, 2024 - STERIS plc (NYSE: STE) has recently announced its plan to sell its Dental segment to Peak Rock Capital, a reputable mid-market private investment firm, for a total consideration of $787.5 million. This divestiture aligns with STERIS strategy to strengthen its focus on providing infection prevention, decontamination, surgical, and ...

Steris Plc

Steris Plc's Strong Financial Performance Sees Double-Digit Revenue Growth in Q3 2024

Steris Plc Reports Strong Financial Results in Q3 2024
Steris Plc, a leading company in the Medical Equipment & Supplies industry, has announced its financial results for the third quarter of 2024. The company reported revenue of $1.40 billion and earnings per share of $1.42. These results indicate a significant year-on-year growth, with revenue increasing by 14.774% and net profit per share growing by 14.52%.
In comparison to its industry peers, Steris Plc's top-line growth outperformed most other companies in the Medical Equipment & Supplies sector during the same reporting period. While the top-line for the two third-party companies in the sector advanced by only 3.13% from the previous year, Steris Plc experienced a much higher growth rate.







Steris Plc's Segments
IRELAND    1.76 % of total Revenue
UNITED STATES    73.15 % of total Revenue
Other foreign locations    25.09 % of total Revenue
Healthcare    71.21 % of total Revenue
Healthcare Capital equipment revenues    18.59 % of total Revenue
Healthcare Consumable revenues    26.14 % of total Revenue
Healthcare Sales Revenue Services Net    26.49 % of total Revenue
Applied Sterilization Technologies    18.83 % of total Revenue
Applied Sterilization Technologies Capital equipment revenues    0.37 % of total Revenue
Applied Sterilization Technologies Sales Revenue Services Net    18.47 % of total Revenue
Life Science Member    9.95 % of total Revenue
Life Science Member Capital equipment revenues    2.27 % of total Revenue
Life Science Member Consumable revenues    5.01 % of total Revenue
Life Science Member Sales Revenue Services Net    2.67 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com